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In vivosilencing holds a great potential for treatment of neurological disorders, its
application to the CNS has been restricted by low levels of tissue distribution and cellular uptake. In this work
we report that cationic lipid-based vectors can enhance siRNA delivery to neurons both in vitro and in vivo.
DOTAP:Chol liposomes associated with transferrin (Tf) and complexed with siRNAs (Tf-lipoplexes) were
delivered to primary cultures of luciferase-expressing cortical neurons. Confocal microscopy studies revealed
efficient cellular uptake of Cy3-labelled siRNAs after Tf-lipoplex delivery, which was reduced but not
completely inhibited by blocking the Tf-receptor with excess Tf. Gene silencing was also evaluated after
delivery of anti-luciferase or anti-c-Jun siRNAs. Our results demonstrate that Tf-lipoplexes achieve up to 50%
luciferase and c-Jun knockdown, 48 h after transfection, without significant cytotoxicity. Similar results were
observed in vivo, where a 40% reduction of luciferase activity was found in the striatum of luciferase mice. In
addition, fluorescence microscopy studies showed extensive local distribution and internalization of Tf-
lipoplex-associated Cy3-siRNAs without tissue toxicity. Overall, our results demonstrate that Tf-lipoplexes
can mediate efficient gene silencing in neuronal cells, both in vitro an in vivo, which may prove useful in
therapeutic approaches to neuronal protection and repair.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The central nervous system (CNS) is the most complex and
specialized organ in the human body, controlling almost all physiolo-
gical processes through the action of neuronal cells. Due to their critical
role, these postmitotic cells are irreplaceable and, once damaged, show
little capacity for functional recovery. One of the major goals of current
neuroscience research is to understand the mechanisms involved in
neuronal degeneration and develop effective therapies to prevent
neuronal cell death associated with neurological disorders.
Although numerous genes and toxic proteins thought to be
involved in neuronal degeneration have been identified [1–3], the
complexity of brain function and the crosstalk between the differenttry, Faculty of Sciences and
3001-401 Coimbra, Portugal.
e Lima),
gy and Toxicology, Faculty of
ch Strasse 1, 35043 Marburg,
l rights reserved.cell death and survival pathways hampers the process of attributing a
specific role to a particular protein. RNA interference (RNAi) has
recently emerged as a powerful tool in functional genomic studies,
allowing to dissect entire signalling pathways and understand the
molecular mechanisms of neurobiological processes [4], thereby
facilitating rapid identification and validation of possible therapeutic
targets. Moreover, RNAi holds a pronounced therapeutic potential
[5,6], since application of small interfering RNAs (siRNAs) may allow
specific knockdown of selected toxic proteins, even when allele-
specific silencing is needed, as in the case of dominantly inherited
disorders [7,8].
Nevertheless, the development of RNAi-based therapeutics for in
vivo application faces the same challenge common to all classes of
drugs: achieving an efficient and sustained distribution into the target
tissue at sufficient concentrations to accomplish a therapeutic effect
[9]. The CNS presents additional obstacles for drug delivery, due to the
presence of the blood-brain barrier and the necessity to target specific
neuronal subpopulations. Since siRNA molecules need to gain access
to the interior of the cell to promote mRNA cleavage, siRNA
stabilization in the extracellular and intracellular environments
during the delivery process and their efficient uptake by neuronal
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Although siRNAs are more resistant to nuclease attack than single-
stranded DNA and RNA, they are still prone to RNase degradation in
biological fluids. Currently, chemicallymodified siRNAswith increased
stability in the presence of serum are already commercially available
and present an improvement for siRNA delivery in vivo [10–13].
Nevertheless, such modifications fail to solve both the poor pharma-
cokinetic properties common to all nucleic acid-based drugs and tissue
specificity [14].
In this context, cationic liposomes can help to significantly increase
the siRNA's circulation time and simultaneously reduce the dose
required for efficient gene silencing by enhancing siRNA stability in
serum and improving cellular uptake [15]. These lipid-based systems
alsopresent ahighdegreeof versatility that allows surfacemodifications
which result in a significant increase of their targeting capacity and
transfection efficiency [15–19]. In this regard, DOTAP:Cholesterol/DNA
complexes have been widely explored by us for both in vitro [15,17,20]
and in vivo [16] gene therapy applications, mainly because of their
capacity to mediate transfection in the presence of serum [18,21–23].
Also, transfection activity can be enhanced by the association of
targeting ligands such as antibodies, peptides or proteins to the
lipoplexes, which exploit the diversity of receptors existent at the
surface of each cell type [19,24–27]. One useful cell-binding ligand is
transferrin (Tf), an iron-transporting protein, which interacts with
receptors ubiquitously expressed in various tissues [28]. Targeting
transferrin receptors has been successfully applied for RNA and DNA
delivery by coupling antibodies against these receptors [29,30], or
transferrin to pegylated liposomes [31], or by associating the protein to
cationic liposomes through electrostatic interactions [15,19,26,32]. In
this regard, we and others have demonstrated that association of Tf to
lipoplexes significantly enhances transfection efficiency by promoting
lipoplex internalization in a large variety of cells [15–17,24,26,33–35],
including neurons. In addition, we have reported that Tf can trigger
cytoplasmic delivery of the carried nucleic acids through destabilization
of the endosomal membrane under acidic conditions, thus further
enhancing the transfection activity [20,24].
However, despite the widespread use of protein-associated
cationic liposomes, there are still very few reports concerning their
application for siRNA delivery to the CNS. We have recently reported
the efficient siRNA complexation and gene silencing mediated by Tf-
lipoplexes in glioblastoma and hepatocarcinoma cell lines [15]. In the
present study, we applied the optimized Tf-lipoplexes to transfer
siRNA targeting the firefly luciferase reporter gene into primary
neuronal cultures obtained from transgenic NF-kB luciferase reporter
mice. We also evaluated Tf-lipoplex-mediated siRNA delivery as well
as luciferase and c-Jun silencing in vivo, after stereotactic injection in
the striatum of the transgenic luciferase reporter mice. The results
presented here demonstrate that Tf-lipoplexes can efficiently promote
siRNA delivery to neuronal cells both, in vitro and in vivo, resulting in
enhanced siRNA internalization and pronounced gene silencing
effects, proposing a significant potential for therapeutic applications.
2. Materials and methods
2.1. Materials
The cationic lipid 1,2 dioleoyl-3(trimethylammonium)propane
(DOTAP) and cholesterol (Chol) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA). Iron saturated human transferrin (Tf) was
obtained from Sigma (St. Louis, MO, USA). The Cy3-labeled non-specific
siRNA sequencewaspurchased fromAmbion (Austin, TX,USA). Theanti-
luciferase siRNA (luciferase Gl2 duplex) and the non-silencing siRNA
usedas controlwere obtained fromDharmacon (Lafayette, CO,USA). The
anti-c-Jun siRNA (5'-AGTCATGAACCACGTTAAC-3') was obtained from
Thermo Bioproducts. All other chemicals were obtained from Sigma
unless stated otherwise.2.2. Animals
All efforts were made to minimize suffering and the number of
animals according to the guidelines of the German animal protection
law and derived guidelines on the ethical use of animals. C57BL/6mice
were obtained from Charles River, Sulzfeld, Germany. NF-κB-lucifer-
ase-reporter mice (genetic background: C57BL/6) were used for the
measurement of NF-κB transcriptional activity as described previously
[36]. The NF-κB-luciferase transgene contained the firefly luciferase
gene, driven by two NF-κB sites responding to p65/p50, p50/cRel and
other dimer combinations of NF-κB as established in previous studies
[37,38]. All animals were kept under controlled light and environ-
mental conditions (12 h dark/light cycle, 23±1 °C, 55±5% relative
humidity) and had free access to food (Altromin, Germany) and water.
The NF-κB-luciferase reporter mouse strain was used because of
several advantages of this transgenic mouse strain compared to other
transgenic reporter mice. Luciferase protein expression can be easily
quantified in various tissues including brain tissue as demonstrated
previously [36,39]. The animals express luciferase in any cell under the
control of a NF-kB binding promoter [38]. Therefore, there is a
constitutive expression of luciferase in any tissue reflecting the
constitutive activity of NF-kB under physiological conditions. It is
not necessary to induce NF-kB or luciferase activity in these animals
for the current application, since luciferase levels are low but easily
detectable in all tissues without further manipulations.
2.3. Liposome and complex preparation
Cationic liposomes composed of DOTAP:Cholesterol (1:1 molar
ratio) were prepared as previously described by Campbell [40] for in
vitro application. Briefly, a mixture of 1 ml of DOTAP and 1.5 ml of
cholesterol in chloroform (from stock solutions of 25 mg/ml DOTAP
and 37.8 mg/ml cholesterol), was dried under nitrogen in order to
obtain a thin lipid film. The film was dissolved in 100 µl of ultrapure
ethanol and the resulting ethanol solution was injected into 900 µl of
HBS buffer (Hepes-buffered saline solution, 20 mM Hepes, 100 mM
NaCl, pH 7.4) maintained continuously under vortex, employing a
250 µl Hamilton syringe. The resulting MLV (multilamellar vesicles)
were sonicated briefly to obtain SUV (small unilamellar vesicles) and
diluted with HBS to a final lipid concentration of 1.43 mM (1 mg/ml).
Alternatively, for in vivo application, the dried lipid film was hydrated
in 1.6 ml of 5% HBG buffer (Hepes-glucose buffer: 5% glucose, 20 mM
Hepes, pH 7.4) and sonicated for 5 min. The resulting liposomes were
then extruded 21 times through two stacked polycarbonate mem-
branes (50 nm pore diameter) and diluted in HBG buffer to a final
DOTAP concentration of 22.5 mM. The liposomes were stored at 4 °C
until use. The size of DOTAP:Cholesterol liposomes is approximately
120 nm, a single and homogeneous population being observed, and
the zeta potential is +70 mV.
For the in vitro studies Tf-lipoplexes were prepared by pre-
incubating a given volume of cationic liposomes (dependent on the
desired (+/−) charge ratio) with iron-saturated human transferrin
(32 µg/µg of siRNA) for 15 min, before mixing the necessary volume of
siRNA stock solution to achieve a final siRNA concentration of 50 or
100 nM in each well. The mixture was further incubated for 30 min, at
room temperature before delivery to cortical neurons in culture.
Alternatively, for in vivo administration, Tf-lipoplexes prepared at a 2/1
lipid/siRNA (+/−) charge ratiowere obtained bymixing 0.8 µl/animal of
the liposome stock solution (22.5 mM DOTAP) with 0.5 µl/animal of
human Tf solution (192mg/ml in HBG), followed by 15min incubation
prior to the addition of 3 µg/animal of siRNAs. The resultingmixturewas
further incubated for 30 min. All formulations were used immediately
after being prepared.Whenmixed according to this protocol, transferrin
(which exhibits a net negative charge) binds electrostactically with the
positive charges of the cationic liposomes, resulting in a slight decrease
in the net positive charge of the formulation but allowing further
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negatively charged molecules.
2.4. Primary cell culture and siRNA delivery
Primary mouse embryonic cortical neurons were obtained from
C57/BL6 transgenic luciferasemice, at day 16 of gestation, as described
previously [41]. After dissociation and centrifugation of the dissected
cortices, the tissue was ressuspended in Neurobasal medium
(Invitrogen, San Diego, CA, USA), enriched with 2% (v/v) B27
supplement (Invitrogen), 2 mM glutamine and 100 U/ml penicillin/
streptomycin (Invitrogen). Cells were plated at a 0.5×106 cells/plate
density in 35 mm Petri dishes previously coated with poly-L-lysine.
Regular characterization of the embryonic neuronal cultures con-
firmed the presence of 95% neurons in these cultures, as determined
by GFAP and NeuN-immunostaining. Primary cultures were kept at
37 °C in a humidified atmosphere containing 5% CO2. After 6 days in
culture, 50 µl of Tf-lipoplexes containing anti-luciferase or non-
silencing (Mut) siRNAs were added to cells to final siRNA concentra-
tions of 50 or 100 nM per well. After a 4 h incubation (in 5% CO2, at
37 °C) the Neurobasal medium was replaced with fresh medium and
the cells were further incubated for different periods of time.
2.5. Confocal microscopy studies
In order to study the cellular uptake of siRNAs and Tf-lipoplexes
and the role of the Tf-receptor in this process, cortical neurons
were incubated for 4 h at 37 °C with naked or Tf-lipoplex-associated
Cy3-labelled siRNAs, prepared at a 3/2 or 2/1 lipid/siRNA charge ratios.
In parallel experiments, the cells were incubated with an excess of free
Tf (10 mg/ml of growth medium) for 1 h at 37 °C before the delivery of
Tf-lipoplexes, whichwere then incubatedwith the cells at 37 °C for 4 h
in the presence of the same excess of Tf. The cells were then washed
with PBS, stained with the fluorescent DNA-binding dye Hoechst
33342 (1 µg/ml) and mounted in PBS for immediate analysis by
confocal microscopy. Confocal fluorescent laser scanning microscopy
was performed by using a Zeiss axiovert system (Zeiss, Jena, Germany)
equipped with an UV laser (364 nm), an argon laser (470, 488 and
514 nm) and two He/Ne lasers (543 nm and 633 nm). Confocal
microphotographs were taken at 4 h and up to 24 h after incubation of
neurons with Cy3-labeled siRNA, using the 60× oil immersion
objective. All pictures were obtained at a pinhole setting that resulted
in analyses of 1 µm slices. Hoechst staining was detected at 364 nm
excitation/385 nm longpass filter emission and Cy3/siGlo was
detected by He/Ne laser 543 nm excitation and 560 longpass filter
emission.
2.6. Evaluation of luciferase activity
Luciferase activity was measured in total protein extracts obtained
from in vitro primary cortical cultures, after delivery of Tf-lipoplexes
containing anti-luciferase or non-silencing (Mut) siRNAs. For in vivo
experiments, total protein extracts were obtained from the dissected
cortex, corpus callosumand striatumofboth contralateral and ipsilateral
brainhemispheres of C57/BL6 transgenicNF-kB luciferase reportermice,
previously injectedwith Tf-lipoplexes containing anti-luciferase or non-
silencing (Mut) siRNAs. Luciferase activity was measured using a
luciferase detection kit, according to the protocol provided by the
manufacturer (Promega,Madinson,WI, USA). Briefly, 48 h after delivery
of Tf-lipoplexes the tissue or cells were lysed with luciferase lysis buffer
(Promega) for 15 min at room temperature. Twenty microliters of
protein extract were removed from each well and added to 100 µl of
luciferase assaybuffer, containing luciferin. Luciferase activity,measured
as relative light units (RLU), was immediately evaluated in a Spectra-
FluorPlus luminometer (Tecan, Männedorf, Switzerland). Total protein
levels in each sample were measured using the BCA protein assay(Pierce, Rockford, IL, USA) and normalization of luciferase activity levels
was performed before statistical analysis. The data were expressed as
percentage of control (non-transfected) samples.
2.7. Evaluation of cell viability and apoptosis
Cell viability of primary neuronal cultures, following Tf-lipoplex
delivery was determined by 3-(4,5dimethylthiazol-2-y1)-2,5-diphe-
nyltetrazolium bromide (MTT) reduction. The MTT assay allows to
measure cell viability through evaluation of changes in the cellular
mitochondrial metabolic activity. Forty-eight hours after transfection,
cellswerewashedwith fresh growthmediumand incubatedwithMTT
(0.25 mg/ml) for 2 h at 37 °C. The reaction was terminated by adding
dimethylsulfoxide solution and the absorbance was determined at
590 nm and 630 nm in an ELISA microplate reader (Spectra FluorPlus;
Tecan, Durham, NC, USA). Cell viability was calculated as percentage of
control cells (non-transfected) using the formula: (A590−A630) of
treated cells×100/(A590−A630) of control cells.
In parallel experiments, following Tf-lipoplex delivery, cultured
neurons were stained with the fluorescent DNA-binding dye Hoechst
33342. Stained nuclei were visualized by epifluorescence microscopy
using a Zeiss Axiovert 200 microscope (Zeiss, Jena, Germany),
equipped with the 20× objective. Neurons with condensed or
fragmented nuclei were considered apoptotic. Two hundred cells
per culture were counted and counts were made in at least six
separate cultures per treatment condition without knowledge of
treatment history. Results were expressed as percentage of apoptotic
cells with respect to control (non-transfected cells).
2.8. Extraction of RNA and cDNA synthesis
Twenty-four hours after anti-c-Jun orMut siRNAdelivery, total RNA
was extracted from 1×106 neuronal cells using the RNeasy Mini Kit
(Qiagen, Hilden, Germany), according to the manufacturer's recom-
mendations for cultured cells. Briefly, after cell lysis, the total RNAwas
adsorbed to a silicamatrix,washedwith the recommended buffers and
eluted with 40 µl of RNase-free water by centrifugation. After RNA
quantification, cDNA conversion was performed using the Superscript
III First Strand Synthesis Kit (Invitrogen, Karlsruhe, Germany),
according to the manufacturer's instructions. For each sample, cDNA
was produced from0.5 µg of total RNA in a iQ 5 thermocycler (Bio-Rad),
by applying the following protocol: 10min at 25 °C, 30min at 55 °C and
5 min at 85 °C. After cDNA synthesis, a 30 min incubation period with
RNase H at 37 °Cwas performed in order to remove any remaining RNA
contamination. Finally, the cDNA was diluted 1:3 with RNase-free
water prior to quantification by QRT-PCR.
2.9. Quantitative Real Time Polymerase Chain Reaction (QRT-PCR)
Quantitative PCR was performed in an iQ 5 thermocycler (Bio-Rad)
using 96-well microtitre plates and the iQ SYBR Green Supermix Kit
(Bio-Rad). The primers for the target gene (c-Jun) and the two tested
house keeping genes (GAPDH andHPRT)were pre-designed byQiagen
(QuantiTect Primer, Qiagen). A master mix was prepared for each
primer set, containing a fixed volume of SYBRGreen Supermix and the
appropriate amount of each primer to yield a final concentration of
150 nM. For each reaction, 20 µl of master mix were added to 5 µl of
template cDNA. All reactions were performed in duplicate (two cDNA
reactions per RNA sample) at a final volume of 25 µl per well, using the
iQ5 Optical System Software (Bio-Rad). The reaction conditions
consisted of enzyme activation and well-factor determination at
95 °C for 1 min and 30 s followed by 40 cycles at 95 °C for 10 s
(denaturation), 30 s at 55 °C (annealing) and 30 s at 72 °C (elongation).
The melting curve protocol started immediately after amplification
and consisted of 1 min heating at 55 °C followed by eighty 10 s steps,
with 0.5 °C increases in temperature at each step. Threshold values for
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the iQ5 Optical System Software. The percentage of c-Jun knockdown
was determined by the ΔΔCt method, using GAPDH as reference gene,
according to the formulas: ΔCt (c-Jun siRNA)=Ct (c-Jun gene)−Ct (GAPDH gene);
ΔCt (Mut siRNA) =Ct (c-Jun gene)−Ct (GAPDH gene); ΔΔCt =ΔCt (c-Jun siRNA)−
ΔCt (Mut siRNA);%knockdown=100%− (2−ΔΔCt ×100). The ΔΔCt value
indicates the changes in RNA transcription caused by treatment with
anti-c-Jun siRNAs, normalized to RNA transcription changes in neurons
treated with Mut siRNAs. When positive, the ΔΔCt value indicates
downregulation of the target mRNA.
2.10. Western blot analysis
Forty-eight or 72 h after anti-c-Jun or Mut siRNA delivery, protein
extracts were obtained from neuronal primary cultures using a lysis
buffer containing protease inhibitors (Sigma). Protein content was
determined using the Bio-Rad protein quantification kit (Bio-Rad) and
20 µg of total protein were resuspended in loading buffer (20%
glycerol, 10% SDS, 0.1% bromophenol blue), incubated for 2 min at
95 °C and loaded onto a 10% polyacrylamide gel. After electrophoresis
the proteins were blotted onto a PVDF membrane according to
standard protocols. After blocking in 5% non-fat milk, the membrane
was incubated with an anti-c-Jun antibody (1:100) (Cell Signalling,
USA) overnight at 4 °C, and with the appropriate secondary antibody
(1:20000) (Amersham, Uppsala, Sweden) for 2 h at room temperature.
Equal protein loading was shown by reprobing the membrane with an
anti-α-tubulin antibody (1:10000) (Sigma) and with the same
secondary antibody. After this incubation period, the blots were
washed several times with saline buffer (TBS/T — 25 mM Tris–HCl,
150 mM NaCl, 0.1% Tween and 5 mg/ml non-fat powder milk) and
incubated with ECF (alkaline phosphatase substrate; 20 µl of ECF/cm2
of membrane) for 5 min at room temperature and then submitted to
fluorescence detection at 570 nm using a VersaDoc Imaging System
Model 3000 (Bio-Rad). For each membrane, the analysis of band
intensity was performed using the Quantity One software (Bio-Rad).
2.11. Stereotactic injection of Tf-lipoplexes
For intrastriatal injections of Tf-lipoplexes or glucose buffer (HBG),
C57/BL6 mice were anaesthetized with halothane and placed in a
stereotactic apparatus. A midline incision was made, the soft tissues
were reflected and a burr hole was made in the skull with the aid of a
surgery micro-drill, at a point 0.0 mm anterior from bregma and
2.5mm lateral from themideline (sagittal suture), according to Paxinos
and Watson [42]. A volume of 2 µl of HBG or Tf-lipoplexes containing
anti-luciferase or non-silencing (Mut) siRNAs were injected at a rate of
0.2 µl/30 s in the right hemisphere (ipsilateral hemisphere) of each
animal, via a stainless steel needle connected to a Hamilton syringe
(Hamilton Bonaduz, Bonaduz, GR, Switzerland), 2.75 mmventral from
dura. Five minutes after the injection was completed, the needle was
withdrawn slowly and the skin was sutured. No symptoms of toxicity
or loss of basic activity were observed in any of the mice receiving Tf-
lipoplexes. The animals were sacrificed in deep halothane anaesthesia
48 h after Tf-lipoplex administration and the brainswere removed and
placed on an acrylic matrix. A two mm section surrounding the
injection sitewas cut with a stainless steel razor and dissected in order
to remove the cortex, corpus callosum andupper half of the striatumof
both hemispheres of each animal for analysis of luciferase activity and
total protein quantification.
2.12. Tf-lipoplex distribution in the brain
In order to study the internalization of Tf-lipoplexes and their in
vivo distribution, a group of C57/BL6 mice received Tf-lipoplexes
containing Cy3-labelled siRNAs in their ipsilateral hemisphere. The
mice were sacrificed under deep halothane anaesthesia 24 h aftertransfection and coronal sections from the striatal region (20 µm)
were cut in a cryostat (Leica CM 3050S, Leica, Wetzlar, Germany) at
−20 °C. The sections were immediately observed by epifluorescence
microscopy under a Zeiss Axiovert microscope, equipped with the 20×
objective and the rhodamine filter or by confocal microscopy under a
Zeiss Axiovert system. Confocal microphotographs were taken using
the 60× oil immersion objective. Cy3/siGlo was detected by He/Ne
laser 543 nm excitation and 560 nm longpass filter emission
2.13. Histological evaluation of Tf-lipoplex toxicity
Forty-eight hours after Tf-lipoplex delivery, the mice were deeply
anaesthetized with an overdose of avertin (10 µl/g) and transcardially
perfused with 20 ml of an ice-cold 0.9% NaCl solution, followed by
20 ml of ice-cold 4% paraformaldehyde in 0.9% NaCl solution. The
brains were removed and postfixed (12 h) in the same fixative
solution, followed by 2–3 days in a cryoprotection solution containing
25% sucrose. After this period, the brains were rapidly frozen in dry
ice, dipped in OCTembeddingmedium (Sakura Finetek, Mijdrecht, The
Netherlands), and 30 µm sections were cut at −20 °C in a cryostat
(Leica) 1000 µm anterior and 1000 µm posterior from the injection
site. The sections were mounted and dried in gelatine-coated glass
slides and each slide was stained for 5 min in 0.5% cresyl violet
solution (Sigma) in acetate buffer, rinsed twice in water, briefly
dehydrated in ethanol, cleared in xylene solution and mounted with
Entellan (Merck). The striatal slices were examined under a Zeiss
Axiovert microscope, equipped with 5× and 20× objectives. Tissuewas
considered damaged when intensively stained condensed or frag-
mented nuclei (pycnotic nuclei) were present and only few healthy
cells remained.
2.14. Statistical analysis
All data are presented as mean±standard deviation (SD). In vitro
data are the result of three independent experiments each performed
at least in triplicate. One Way ANOVA analysis of variance combined
with Tukey posthoc test was used for multiple comparisons in cell
culture experiments.
In vivo datawere analysed by the Kruskal–Wallis OneWay Analysis
of Variance, followed by the Dunnett's posthoc test for multiple
comparisons between groups. Statistical differences are presented at
probability levels of pb0.05, pb0.01 and pb0.001. Calculations were
performed with standard statistical software (GraphPad Prism 4).
3. Results
3.1. Cellular uptake of fluorescently labelled siRNAs
In order to study the in vitro uptake of Tf-lipoplexes by neuronal
cells, the internalization and distribution of naked or Tf-lipoplex-
associated Cy3-labelled siRNAs were evaluated by confocal micro-
scopy in primary cortical cultures 24 h following delivery. The
results shown in Fig. 1 reveal that at this time point cells treated
with Tf-lipoplexes, prepared at 3/2 or 2/1 lipid/siRNA charge ratios
(panels a–f), present intense red fluorescence throughout the
cytoplasm and nucleus, indicating widespread distribution of labelled
siRNAs. In contrast, the delivery of the same amount of naked Cy3-
siRNAs (panels g–i) did not allow detection of red fluorescence inside
the cells or even in the extracellular medium, indicating that naked
siRNAs are not efficiently internalized, whichmay be due to inefficient
binding to the cell surface, most likely as a result of washing or RNase-
related degradation.
It has been demonstrated that Tf is highly effective in promoting
lipoplex-mediated transfection in various cell lines and primary cell
cultures [15–17,26]. Our previous studies have also suggested that Tf
enhances cellular uptake of lipoplexes and induces destabilization of
Fig. 1. Uptake of naked or Tf-lipoplex associated Cy3-siRNAs in primary neuronal cultures. Primary cultures of cortical neurons were maintained in culture for 6 days before
transfection. DOTAP:Chol liposomes were complexed, in the presence of Tf (32 µg/µg siRNA), with 50 pmol non-silencing Cy3-labelled siRNA (red) at the indicated lipid/siRNA charge
ratios, and then incubated with the cells for 4 h to a final siRNA concentration of 50 nM. In parallel experiments, the same amount of naked siRNAs was added to the cells. After 4 h
incubation, the medium was replaced and the cells were further incubated for 24 h. Cells were then fixed, the nuclei were labelled with Hoechst 33342 (blue) and Cy3-siRNA
internalization was evaluated by confocal microscopy. Confocal laser scanning images were acquired in the red (left panels) and blue channels (middle panels) and images
representative of three independent experiments are presented separately and as a merged image (right panels) at 600× magnification.
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[19,20]. Aiming at examining the role of Tf-receptors in siRNA uptake
mediated by Tf-lipoplexes, primary neuronal cultures were pre-
incubated in the presence or absence of iron-saturated Tf (holo-Tf) for
1 h at 37 °C, before the addition of Tf-lipoplexes containing Cy3-
labelled siRNAs. Fig. 2 illustrates the effect of pre-incubating neuronal
cultures with 10 mg/ml of free Tf (approximately 100 times the
amount of protein that is associated with the lipid/siRNA complexes)
on both Tf-lipoplex internalization (Fig. 2a) and Tf-lipoplex-mediated
gene silencing (Fig. 2b). As observed in Fig. 2, the presence of this large
excess of Tf during the transfection period reduces the number of
fluorescent particles located inside the cells 4 h after Tf-lipoplex
delivery (Fig. 2, panels i and ii). This effect is even more pronounced at
24 h after delivery, where a significant decrease in intracellular
fluorescence is observed in cells incubated with excess of Tf (Fig. 2,
panels iii and iv). Nevertheless, a low intensity of red fluorescence can
still be observed, suggesting that under this condition a small degree
of internalization did still occur. In order to study the effect of the
excess of free Tf on transfection efficiency, parallel experiments were
performed in neurons treated with Tf-lipoplexes prepared at the 3/2
and 2/1 lipid/siRNA charge ratios and containing anti-luciferase
siRNAs (Fig. 2b). Luciferase activity was measured 48 h after
transfection. The decrease in luciferase activity reached 50% for both
charge ratios in the absence of excess Tf (normal medium), compared
with only a 15% and 25% reduction for the 3/2 and 2/1 lipid/siRNA
charge ratios, respectively, in the presence of excess Tf. Altogether,
these results indicate that Tf-lipoplex internalization is highly
dependent on the availability of Tf-receptors on the cell surface,although non-specific cell interactions also contribute to transfection
efficiency.
3.2. Gene silencing efficiency and biocompatibility of Tf-lipoplexes
To assess the silencing efficiency in vitromediated by Tf-lipoplexes
and to exclude possible off-target effects caused by the vector per se or
by the transfection process, the levels of luciferase gene expression
were measured in luciferase-expressing primary neuronal cultures,
48 h after delivery of anti-luciferase (Luc) or non-silencing (Mut)
siRNAs (Fig. 3). Parallel transfection experiments employing Lipofec-
tamine 2000, which is frequently used for in vitro DNA and siRNA
delivery, were performed for comparison. As shown in Fig. 3, both
lipoplex formulations (3/2 and 2/1 lipid/siRNA charge ratios) achieved
approximately 50% reduction in luciferase activity, when prepared
with Luc siRNAs, a result which is slightly higher than that obtained
with the standard reagent — Lipofectamine 2000. Gene silencing was
found to be specific, since no significant decrease in luciferase levels
was observed for both formulations with Mut siRNAs at concentra-
tions of 50 nM. It should be noted that the increase in siRNA
concentration to 100 nM resulted in a slight improvement in luciferase
knockdown but was also accompanied by non-specific silencing, as
shown by the decrease of luciferase activity obtained for this
concentration when employing Mut siRNAs. This finding demon-
strated that optimization of the siRNA concentration is always
necessary to achieve both efficient and specific silencing effects.
Postmitotic neuronal cells are more susceptible to cationic lipid-
induced toxicity than most cell lines and other primary cultures of
Fig. 3. In vitro gene silencing mediated by Tf-lipoplexes. Primary cultures of cortical
neurons were maintained in culture for 6 days before transfection. DOTAP:Chol
liposomes were complexed, in the presence of Tf (32 µg/µg siRNA), with 50 pmol or
100 pmol of anti-Luciferase (Luc) or non-silencing (Mut) siRNA at the indicated lipid/
siRNA charge ratios, and then added to the cells at a final siRNA concentration of 50 nM
or 100 nM, respectively. In parallel experiments, cortical neurons were incubated with
50 pmol of anti-Luciferase (Luc) or non-silencing (Mut) siRNAs complexed with
Lipofectamine at a final siRNA concentration of 50 nM. After 4 h incubation, themedium
was replaced and the cells were further incubated for 48 h. Luciferase activity was
measured in each sample as relative light units (RLU) and calculated as percentage of
activity in control (non-transfected) cells. Mean RLU±S.D. was obtained from three
independent experiments, each performed in triplicate. ⁎pb0.05 and ⁎⁎pb0.01
compared to cells treated with Mut siRNA.
Fig. 2. Effect of excess of transferrin on Tf-lipoplex uptake and transfection efficiency in
primary neuronal cultures. Primary cultures of cortical neurons were maintained in
culture for 6 days before transfection. DOTAP:Chol liposomes were complexed, in the
presence of Tf (32 µg/µg siRNA), with 50 pmol of (a) non-silencing Cy3-labelled siRNAs
(red) or (b) anti-luciferase siRNAs and added to the cells to a final siRNA concentration
of 50 nM. (a) Cells were incubated with Tf-lipoplexes prepared at a 3/2 lipid/siRNA
charge ratio, for 4 h in the absence of a pre-treatment with Tf (panels i and iii) or in
medium supplemented with excess of Tf (10 mg/ml) (panels ii and iv). Four or 24 h after
transfection, cells were fixed and the nuclei labelled with Hoechst 33342 (blue). The
extent of Cy3-siRNA internalization was evaluated by confocal microscopy. Represen-
tative confocal laser scanning images are presented as merged images at 600×
magnification. Experiments were performed at least three times. (b) Cells were
incubated for 4 h with Tf-lipoplexes at the indicated charge ratios. After this period the
mediumwas replaced and the cells were further incubated for 48 h before evaluation of
transfection efficiency. Luciferase activity was measured in each sample as relative light
units (RLU) and calculated as percentage of activity in control (non-transfected) cells.
Mean RLU±S.D. was obtained from three independent experiments, each performed in
triplicate. ⁎pb0.05 and ⁎⁎pb0.01 compared to cells transfected without pre-treatment
with excess Tf.
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cultures in vitro, cell viability was assessed by the MTT assay 48 h after
transfection. Results presented in Fig. 4a show that no significant
change in cell viability was observed after delivery of Tf-lipoplexes,
independently of the employed lipid/siRNA charge ratio, when the
final siRNA concentration was 50 nM. Nevertheless, Tf-lipoplexes
prepared for a final siRNA concentration of 100 nM, presented a slight
toxic effect leading to approximately 20% decrease in cell viability,
which strongly correlates with the non-specific effect observed for Tf-lipoplexes at high siRNA concentrations (Fig. 3). In parallel studies, the
number of pycnotic nuclei was evaluated in neuronal cultures 48 h
after Tf-lipoplex delivery. As shown in Fig. 4b, no significant increase
in the number of condensed nuclei was observed after transfection in
the presence of 50 nM siRNAs, whereas a two-fold increase was
obtained following delivery of 100 nM siRNAs, which is consistent
with the results from the MTT assay. On the other hand, neurons
transfected with 50 nM siRNA complexed with Lipofectamine showed
a three-fold increase in the number of cells with abnormal nuclear
morphology.
3.3. Tf-lipoplex-mediated c-Jun mRNA and protein knockdown in
primary neuronal cultures
In order to demonstrate that Tf-lipoplex ability to promote efficient
gene silencing is not restricted to specific reporter targets, such as
luciferase, an endogenous gene was selected to further investigate Tf-
lipoplex transfection properties. The well described transcription
factor (c-Jun), whose role in the apoptotic process is currently being
investigated, was chosen as target and a complementary siRNA was
synthesized based on the mouse c-Jun mRNA sequence. To establish
the average decrease in c-Jun mRNA levels (Table 1), cortical neurons
were incubated with Tf-lipoplexes prepared at the 3/2 lipid/siRNA
charge ratio and containing anti-c-Jun or non-functional Mut siRNAs.
Twenty-four hours after Tf-lipoplex delivery, c-Jun mRNA silencing
was evaluated using QRT-PCR. The percentage of c-Jun knockdown in
these cells was calculated using the ΔΔCt method, as described in the
Materials and methods section. In these experiments, the mean ΔΔCt
value found was 1.22, which translates into 54% of c-Jun knockdown.
Moreover, two endogenous reference genes, whose expression should
not differ between samples, were used in this study as normalization
controls. The expression levels of both GAPDH and HPRTgenes did not
Fig. 5. Western blot quantification of Tf-lipoplex-mediated c-Jun knockdown in
neurons. Primary cultures of cortical neurons were maintained in culture for 6 days
before transfection. DOTAP:Chol liposomes were complexed, in the presence of Tf
(32 µg/µg siRNA), with 50 pmol of siRNA at the 3/2 (+/−) lipid/siRNA charge ratio, and
then added to the cells to a final siRNA concentration of 50 nM. After 4 h incubation, the
mediumwas replaced and the cells were further incubated for 48 h or 72 h before c-Jun
and α-tubulin quantification by immunoblotting. (a) Representative gel showing c-Jun
knockdown. (b) Quantification of c-Jun silencing observed in (a), corrected for
individual α-tubulin signal intensity. Results are expressed as percentage of c-Jun
expression levels with respect to untreated controls. ⁎⁎⁎pb0.001 compared to control
(non-treated) neurons.
Table 1
QRT-PCR quantification of Tf-lipoplex-mediated c-Jun knockdown in neuronal cells
Neuronal cells Ct
c-Jun
Ct
GAPDH
ΔCt ΔΔCt c-Jun
knockdown (%)
Average c-Jun
knockdown (%)
Transfected with
anti-c-Jun siRNA
34.93 20.62 14.31 1.08 53
32.90 20.90 12.00 0.6 34 54
35.21 20.10 15.10 1.98 75
Transfected with
Mut siRNA
34.21 20.98 13.23
31.90 20.50 11.40
33.37 20.25 13.12
The levels of both c-Jun and HPRT genes were determined by quantitative RT-PCR 24 h
after transfection. c-Jun knockdownwas evaluated by the ΔΔCt method (n=3) using the
GAPDH gene as reference gene. Results are expressed as a percentage of c-Jun
expression in cells treated with Mut siRNAs.
Fig. 4. Effect of Tf-lipoplexes on the viability of primary neuronal cultures. Primary
cultures of cortical neurons were maintained in culture for 6 days before transfection.
DOTAP:Chol liposomes were complexed, in the presence of Tf (32 µg/µg siRNA), with
50 pmol or 100 pmol of siRNA at the indicated lipid/siRNA charge ratios, and then added
to the cells to a final siRNA concentration of 50 nM or 100 nM, respectively. In parallel
experiments, cortical neurons were incubated with 50 pmol of non-silencing (Mut)
siRNAs complexed with Lipofectamine at a final siRNA concentration of 50 nM. After 4 h
incubation, the medium was replaced and the cells were further incubated for 48 h.
(a) Cell viability was determined by theMTTassay. The data are expressed as percentage
of control (non-transfected) cells. (b) Apoptotic cells were visualized after labelling of
nuclei with Hoechst 33342. For each condition, the number of pycnotic nuclei is
expressed as the percentage of total number of nuclei. Results were obtained from three
independent experiments, each performed in triplicate. ⁎pb0.05 and ⁎⁎⁎pb0.001
compared to control (non-treated) neurons.
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Tf-complexes, which indicates that no unspecific mRNA downregula-
tion occurs attributable to the vector per se.
The efficiency of siRNA-mediated gene silencing was confirmed by
Western blot analysis. In parallel experiments, neurons exposed to a
similar transfection protocol were collected and lysed 48 or 72 h
following Tf-lipoplex delivery. Fig. 5a illustrates a pronounced protein
knockdown, obtained after Tf-lipoplex-mediated delivery of anti-c-
Jun siRNAs. The protein quantification analysis (Fig. 5b) performed 48
and 72 h after siRNA delivery, shows similar results for both tested
time points, indicating approximately 45% decrease in c-Jun levels
with respect to control. These results were found to be specific, since
no relevant c-Jun knockdown was observed with Mut siRNA and the
levels of α-tubulin were constant for all tested formulations.3.4. In vivo Tf-lipoplex-mediated delivery of Cy3-labelled siRNAs
We have previously demonstrated that association of Tf to
lipoplexes promoted efficient delivery of DNA in vivo [16]. Therefore,
in this work we evaluated whether this strategy would also result in
the enhancement of siRNA delivery to the mouse brain. For this
purpose, C57/BL6 mice were injected with Tf-lipoplexes prepared at a
2/1 lipid/siRNA charge ratio and containing 3 µg of Cy3-labelled
siRNAs. The injection was performed in the striatum of the right
hemisphere (ipsilateral hemisphere) of each animal and observation
of the neuronal tissue of these animals wasmade 24 h after Tf-lipoplex
delivery. Fig. 6a provides evidence that stereotactic injection of Tf-
lipoplexes leads to efficient siRNA delivery in vivo, as observed by the
high number of red-labelled cells in the ispsilateral hemisphere
(Fig. 6a, panel i) and the intracellular localization of the Cy3-siRNAs
observed by confocal microscopy (Fig. 6a, panels iii and iv) in z-stack
Fig. 7. In vivo luciferase silencing mediated by Tf-lipoplexes. Animals were injected
stereotactically, in the striatum of the right (ipsilateral) hemisphere, with Tf-lipoplexes
containing 3 µg of anti-luciferase (Luc) or non-silencing (Mut) siRNAs, prepared at the 2/1
lipid/siRNA charge ratio in a volume of 2 µl, or with an equal volume of vehicle (HBG); no
injection was performed in the left (contralateral) hemisphere. Animals were sacrificed
48 h postinjection and luciferase activity was evaluated in the striatum, corpus callosum
and cortex of both hemispheres of each animal. Luciferase activity was measured in each
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the contralateral hemisphere (Fig. 6a, panel ii). In all injected animals
the red fluorescence was distributed throughout the entire superior
region of the striatum, mostly pronounced in the area surrounding the
injection site, but was not observed in other adjacent brain regions
such as the cortex or corpus callosum.
In order to evaluate Tf-lipoplex biocompatibility, counterstaining of
brain slices with cresyl violet was performed. No relevant signs of
toxicity were found throughout the ipsilateral striatumwhere, similarly
to observations in the contralateral hemisphere, neurons presented a
light violet colour and large cell body characteristic of healthy cells (Fig.
6b). The presence of vacuolization or large number of apoptotic cells
was not detected in any of the injected animals and only a small number
of pycnotic cells were observed in the tissue surrounding the injection
site. These dark coloured and shrunken cells were present in the slices
showing the injection tract, and are a common consequence of tissue
damage occurring during the insertion of the injection needle.
3.5. In vivo luciferase silencing mediated by Tf-lipoplexes
In order to evaluate the in vivo gene silencing activity of Tf-
lipoplexes, transgenic Nf-kB luciferase reporter mice were injected intissue sample as relative light units (RLU) and calculated as percentage of activity with
respect to the contralateral (non-injected) hemisphere, after normalization to total protein
levels. Results are expressed as mean RLU±SD obtained from n=5 animals per group.
⁎⁎pb0.01 compared to striatum luciferase levels of both HBG and Mut siRNA-treated
animals.
Fig. 6. Tf-lipoplex-mediated internalization and biocompatibility of Cy3-labelled siRNAs in
vivo. Animals were injected stereotactically, in the striatum of the right (ipsilateral)
hemisphere,with Tf-lipoplexes containing 3 µg of Cy3-labelled siRNAs and prepared at the
2/1 lipid/siRNA charge ratio; no injection was performed in the left (contralateral
hemisphere). Animals were sacrificed 24 h postinjection and (a) Tf-lipoplex-mediated
internalization of Cy3-siRNAs was evaluated in 30 µm coronal brain sections by
fluorescence microscopy (panels i and ii) or confocal microscopy (panels iii and iv).
Biocompatibility of Tf-lipoplexes was evaluated in adjoining sections by cresyl violet
staining (b). (a) Representative fluorescence microscopy images of (i) ipsilateral and
(ii) contralateral hemispheres are presented at 1000× magnification. Representative z-
stack images of the same brain region in the ipsilateral hemisphere are presented at a
6000× magnification (iii). A specific area of each z-stack image was zoomed 2× to obtain
close-up images showing intracellular localization of Cy3-siRNAs (iv). (b) Representative
microscopy imagesof (i) ipsilateral and (ii) contralateral hemispheres are presented atboth
2000× and 500× magnifications. The black arrows indicate the region further magnified.the striatum of the right (ipsilateral) hemisphere with 3 µg of Luc or
Mut siRNAs complexed with Tf-containing DOTAP:Chol liposomes, in
a final injection volume of 2 µl. In parallel experiments, a third group
of animals received an injection of HBG buffer (2 µl) which was used
for Tf-lipoplex preparation. Fig. 7 presents the levels of luciferase
activity observed in the ipsilateral upper striatum and adjacent
regions (cortex and corpus callosum) of each animal group 48 h after
Tf-lipoplex delivery. Results are expressed as the percentage of
luciferase activity compared to the non-injected (contralateral)
hemispheres. The Luc siRNA-treated group presented a significant
decrease (approximately 40%) of luciferase levels in the ispsilateral
striatal tissue, whereas no luciferase knockdown was detected in the
ipsilateral cortex or corpus callosum of these animals. The fact that no
decrease in luciferase activity was observed after transfection with
Mut siRNAs indicates that Tf-lipoplex-mediated gene silencing in vivo
does not present detectable unspecific effects when low siRNA and
lipid concentrations are used. Also, no significant increase in luciferase
expression was detected in the ipsilateral hemispheres of the animals
treated with Mut siRNAs or HBG, suggesting that the injection per se
did not induce any unspecific NF-kB activation.
Altogether these results clearly show that Tf-lipoplexes are able to
mediate efficient siRNA delivery and gene silencing, both in neuronal
primary cultures and in the mouse brain, with high specificity and
minimum toxicity.
4. Discussion
In this work we provide evidence that Tf-lipoplexes, a cationic
lipid-based formulation, previously employed in our recent work for
siRNA delivery in vitro [15] and DNA delivery to neuronal cells in vitro
[17] and in vivo [16], can efficiently mediate siRNA delivery into
neuronal primary cultures, using low amounts of siRNA and low lipid/
siRNA charge ratios. Confocal microscopy revealed that both charge
ratios tested (3/2 and 2/1 lipid/siRNA) led to the intracellular
localization of Cy3-siRNAs 24 h after delivery (Fig. 1, panels a–f). In
contrast, after incubation with naked Cy3-labelled siRNAs, no
fluorescence was observed inside or outside the neuronal cells
(Fig. 1, panels g–i). These results are very similar to those obtained
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uptake of naked siRNAs, that is likely attributable to nuclease-
mediated degradation and low binding affinity to the cell membrane.
The data also suggest that Tf-lipoplexes increase significantly the rate
of siRNA internalization in neuronal cells, probably by protecting the
nucleic acids from nuclease-mediated degradation and by enhancing
siRNA uptake through the endocytic pathway.
In order to clarify the actual mechanisms of Tf-lipoplex-mediated
siRNA delivery and to evaluate the contribution of Tf-receptors in this
process, we examined Cy3-siRNA internalization in the presence of an
excess of holo-transferrin (100 times more than the amount used for
Tf-lipoplex preparation) at 4 and 24 h after transfection. Results in
Fig. 2a show that Tf-lipoplex internalization is partly inhibited in the
presence of large amounts of Tf, as judged by the low intracellular
fluorescence levels observed for both incubation times (Fig. 2, panels ii
and iv), as compared to those found in the absence of any excess of
Tf (Fig. 2, panels i and iii). The fact that excess Tf does not completely
inhibit Cy3-siRNA uptake suggests that the cell internalization of Tf-
lipoplexes containing siRNAs is mediated by both specific, i.e. Tf-
receptor-dependent, and non-specific, Tf-receptor-independent pro-
cesses. This partial unspecificity was confirmed by the results
obtained with the luciferase assay (Fig. 2b), after delivery of Tf-
lipoplexes containing anti-luciferase (Luc) siRNAs. These studies show
that pre-saturation of Tf-receptors with excess of free Tf leads to a
decrease in gene silencingmediated by Tf-lipoplexes prepared at a 3/2
lipid/siRNA charge ratio, as compared to cells transfected in normal
medium, while gene silencingmediated by Tf-lipoplexes prepared at a
2/1 lipid/siRNA charge ratio was only slightly affected. The observation
that the inhibition of transfection is less significant for the 2/1 lipid/
siRNA charge ratio might be explained by the excess positive charge in
this formulation, which can promote non-specific receptor-mediated
uptake of the Tf-lipoplexes, in a similar way to what was previously
observed for DNA-containing Tf-lipoplexes. This effect can be
attributed to the establishment of pronounced electrostatic interac-
tions between the negatively charged cell membrane and the positive
charges of the cationic lipid, which promote Tf-lipoplex binding to the
cell surface.
Taken together, the results presented in Fig. 2 suggest that Tf-
lipoplex internalization is mediated by both Tf-receptor-dependent
and -independent mechanisms. The Tf-receptor-independent mecha-
nism,which seems to be themost relevant to successful gene silencing,
presents a strong dependence on the presence of an excess of positive
charges. These results partly correlate with those from previous work
on the cellular uptake of DNA-containing Tf-lipoplexes, in which it is
clearly shown that Tf-lipoplex internalization ismostly independent of
the Tf-receptors[19]. Here, we show that gene silencing is only slightly
affected by the presence of excess Tf, especially when Tf-lipoplexes
are prepared at a high charge ratio. Although in our previous work, no
role was attributed to Tf-receptors in Tf-lipoplex internalization, in
the present study a small percentage of Tf-lipoplexes carrying siRNA
seems to be internalized and mediate a gene silencing effect through
Tf-receptors, which may be explained by small differences in the
structure of the complexes. In both cases, transferrin was electro-
statically associated to the cationic liposomes, prior to complexation
with DNA or siRNA. In the case of DNA-containing Tf-lipoplexes, it
is possible that the transferrin binding motifs are not available at the
surface of the lipoplexes to bind to its receptors on the target cells.
On the other hand, in the case of siRNA-containing Tf-lipoplexes, the
small size of siRNA molecules may allow exposure of some of the Tf
binding moieties, allowing the binding of Tf-lipoplexes to transferrin
receptors.
In order to evaluate the biological activity and gene silencing
potential of Tf-lipoplexes in vitro, we performed transfection experi-
ments employing Luc or non-silencing (Mut) siRNAs in neuronal
primary cultures obtained from luciferase-expressing transgenicmice.
A large body of evidence including our own work suggests that thereare significant differences in gene silencing efficiency when compar-
ing siRNA protocols in transiently transfected cells with the same
siRNA application in stably transfected cells or when targeting
endogenous protein expression. Usually, siRNA appears to be very
potent when applied as a co-transfection with the targeted reporter
gene in transiently transfected cells. However, the same protocol is far
less efficient when targeting the same reporter gene in stably
transfected cells. Therefore stably transfected cells present better
models than transiently expressing cells and should be preferentially
used in gene silencing studies. The transgenic model (expression of
single genomic copy driven by a NF-kB responsive promoter),
employed throughout this work, is even a better approach considering
that luciferase is expressed like an endogenous gene in these mice. In
fact, we have demonstrated this when transferring according siRNA
protocols for luciferase silencing to applications in wildtype neurons
and neuronal cell lines where we successfully silenced endogenous
expression of c-Jun, Bid or AIF [15,41].
The results presented in Fig. 3 clearly demonstrate that Tf-
lipoplexes can mediate an efficient downregulation of the luciferase
genewith concomitant decrease in luciferase activity (50%) for a siRNA
concentration of 50 nM. Our observations also suggest that this is the
ideal siRNA concentration to achieve highly specific gene knockdown
in neuronal cultures. As illustrated in Fig. 3, the increase of siRNA
concentration to 100 nM, although slightly improving gene silencing,
enhanced the downregulation of the luciferase gene by the Mut
sequence which is a clear indicator of non-specific effects. This result
once again stresses the importance of always using the lowest
effective dose of both siRNA and delivery agent in order to reach a
balance between efficiency and specificity, minimizing non-specific
protein decrease and thereby reducing the risk of an immune reaction,
mediated through Toll-like receptor activation [43–45].
The in vitro toxicity assays (Fig. 4) revealed that cell viability was
not affected upon transfection with Tf-lipoplexes prepared at low
siRNA concentrations for both charge ratios tested. Also, no significant
increase in the number of apoptotic cells was observed for these
formulations when compared to control (non-transfected) cultures.
The increase of siRNA concentration to 100 nM induced a decrease in
cell viability of approximately 20%, and an increase of 10% in the
number of pycnotic nuclei. Notably, even at this siRNA concentration,
Tf-lipoplexes presented better biocompatibility than Lipofectamine
2000, which increased the percentage of apoptotic cells to 20% when
complexed with 50 nM siRNA.
In order to further elucidate the potential of Tf-lipoplexes to
mediate gene silencing of endogenous genes, and in linewith previous
results obtained in neuronal cell lines [15], we selected the c-Jun gene
as target and investigated c-Jun knockdown in neuronal primary
cultures. The QRT-PCR results presented in Table 1 show a significant
downregulation of c-Jun mRNA (54%) 24 h after delivery of Tf-
complexes, without detectable off-target effects. Moreover, following
Western blot analysis, a noteworthy reduction of c-Jun protein levels
(45%) was also observed in these cells (Fig. 5), Due to its important role
as a transcription factor in several intracellular apoptotic pathways, c-
Jun is being currently studied as a promising target for the treatment
of neurodegenerative conditions and excitotoxic brain injury (manu-
script in preparation). These results clearly show the ability of Tf-
lipoplexes to mediate gene silencing of endogenous targets, such as c-
Jun, which illustrates the potential of this formulation to help both in
the clarification of the molecular mechanisms involved in this type of
neuronal cell death and in the increase of cell survival following Tf-
lipoplex-mediated target silencing.
Once overcoming the first obstacles for achieving gene silencing in
neuronal cultures, which mainly concern the efficient uptake of intact
siRNA molecules and their release into the cytoplasm, the in vivo
application of siRNAs to the brain still faces major challenges due to the
poor accessibility of this organ and its complex physiology. We have
previously shown that DOTAP:Chol liposomes associated with
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vivo following local injection [16]. In the present work, we investigated
whether similar results would be observed for Tf-lipoplex-mediated
siRNA delivery. In order to study in vivo siRNA uptake, Cy3-labelled
siRNAs were injected into the mouse striatum and the distribution of
intracellular fluorescence was observed 24 h after transfection by both
fluorescence and confocal microscopy. Our results indicate that the
tested formulation is able to mediate delivery of siRNA molecules in an
extensive area surrounding the injection site (Fig. 6a) without any signs
of neuronal toxicity, as observed by cresyl violet counterstaining
(Fig. 6b). Z-stack confocal images (Fig. 6a, panels iii and iv) also show
that Cy3-siRNAs are efficiently internalized by neurons following Tf-
lipoplex delivery. Results from parallel experiments employing Cy3-
labelled siRNAs naked or formulated in lipoplexes in the absence of
transferrin (plain lipoplexes) showed that no siRNAuptakewas detected
in the case of nakedCy3-siRNAs, andonlya small numberof cells close to
the injection site showed red labelling when plain lipoplexes were used
(data not shown). These data further illustrate the role of transferrin in
enhancing lipoplex uptake in neuronal cells. Studies performed in
transgenic animals stably expressing luciferase clearly demonstrated
that significant downregulation of a reporter protein could be achieved
through Tf-lipoplex-mediated gene silencing. The results presented in
Fig. 7 indicate a specific siRNA-induced decrease in luciferase activity in
the striatum. Approximately 40% of such decrease was confined to this
brain region and was only detected after anti-luciferase siRNA delivery,
clearly demonstrating that the observed gene silencing effect is
attributed to the selected siRNA sequence and not to non-specific effects
of the vector per se. It is also important to note that no significant
increase in luciferase expression was detected in the ipsilateral hemi-
spheres of the animals treated with Mut siRNAs or HBG, with respect to
contralateral hemispheres. A significant advantage of the NF-kB
luciferase reporter system is the capability to indicate adverse effects
that may be caused by siRNA applications. For example, potential
immunogenic or inflammatory reactions after local siRNA application
would result in a significant NF-kB activation and thus increased
luciferase activity, easily detectable in the different treatment groups.
Toxic effects resulting in a general inhibition of protein synthesis or cell
deathwould likewise be easily detected in animals receiving the vehicle
or non-functional control siRNA. The data presented in Figs. 6 and 7
clearly demonstrate that local applicationof the siRNA lipoplexes didnot
cause any of these potential adverse effects besides the desired specific
silencing of luciferase.
It should be stressed that although 40% gene downregulation does
not lead to full protein knockdown, it will be sufficient to promote a
significant therapeutic effect, which may be particularly important in
certain cases where the complete abolishment of a given protein could
exert deleterious effects to the cells. This is case when the target
protein presents multiple, even contradictory, physiological roles. The
transcription factor c-Jun is one of such proteins, which in normal
conditions regulates the expression of multiple essential proteins and,
therefore, is vital per se to cell survival, but can also be strongly
involved in pro-apoptotic mechanisms following injury.
5. Conclusion
Overall, our results demonstrate that, similarly to what was
previously shown for plasmid DNA, Tf-lipoplexes are able to promote
siRNA transfection in neuronal cells, both in vitro and in vivo, with
high efficiency and minimum toxicity, which clearly shows their
potential regarding the downregulation of neurological disease-
related genes for future therapeutic application.
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